PendoTECH Develops Single-Use Bioprocessing Sensors Using Solvay Polymer

PendoTECH has developed sensors for single-use biopharmaceutical continuous processing applications using Solvay’s Udel® P-1700 polysulfone (PSU) polymer.
Increased Ribosome Biogenesis

Inhibiting Ribosomal Biogenesis Opens New Path to Cancer Therapy

Researchers from Uppsala University report that the metastatic process is helped by the synthesis of new ribosomes. The results open the possibility for new treatment strategies for advanced cancers, according to the scientists whose...
Source: Sartorius Stedim Biotech

Sartorius Inks Automation Cooperation Agreement with Siemens

Sartorius Stedim Biotech and Siemens agree to a long-term cooperation agreement in the area of automation

Danaher Buys Pall for $13.8B; Separating Into Two Companies

Pall’s operations will be folded into one of the new companies, which will retain the Danaher name and focus on “science and technology growth.”

BI Licenses ProBioGen’s GlymaxX Platform for Fucose-Free Antibody Production

Firm’s contract manufacturing business will combine technology with BI-HEX expression system.

Selexis Provides Zyngenia with Cell-Line Services for Antibody Production

Firm claims Genetic Elements platform can reduce development time to five weeks.

Lonza Wins U.S. Gov’t iPSC Manufacturing Contract

Lonza won a roughly $9.5 million National Institutes of Health Center for Regenerative Medicine (NIH CRM) contract for the cGMP manufacture of induced pluripotent stem cells (iPSCs) and clinical-grade iPSC-derived cell types.

Samsung Biologics, BMS in Manufacturing Partnership

Samsung Biologics and Bristol-Myers Squibb have entered into a 10-year agreement under which Samsung will manufacture an antibody cancer drug for BMS.

Domain Collabs with Canadian Universities on Biosensor Technology

Domain Therapeutics inked a licensing and partnership agreement on G-protein coupled receptors (GPCR) biosensor technology with Université de Montréal (UdeM) and its commercialization unit, with the Institute for Research in Immunology and Cancer–Commercialization of...

Patheon Consolidates Production Activities in Puerto Rico

Contract development and manufacturing services firm offers preclinical development through to commercial manufacturing of parenteral, solid, semisolid, and liquid dosage forms.

Recently Featured

Stay Connected

555,651FansLike
48,122FollowersFollow
Scroll Up